1. Two versus five stereotactic ablative radiotherapy treatments for localized prostate cancer: A quality of life analysis of two prospective clinical trials. (November 2019) Authors: Alayed, Yasir; Quon, Harvey; Cheung, Patrick; Chu, William; Chung, Hans T.; Vesprini, Danny; Ong, Aldrich; Chowdhury, Amit; Panjwani, Dilip; Helou, Joelle; Pang, Geordi; Korol, Renee; Davidson, Melanie; Ravi, Ananth; McCurdy, Boyd; Zhang, Liying; Mamedov, Alexandre; Deabreu, Andrea; Commisso, Ang... Journal: Radiotherapy and oncology Issue: Volume 140(2019) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Stereotactic ablative radiotherapy in the treatment of low and intermediate risk prostate cancer: Is there an optimal dose?. Issue 3 (June 2017) Authors: Helou, Joelle; D'Alimonte, Laura; Quon, Harvey; Deabreu, Andrea; Commisso, Kristina; Cheung, Patrick; Chu, William; Mamedov, Alexandre; Davidson, Melanie; Ravi, Ananth; Loblaw, Andrew Journal: Radiotherapy and oncology Issue: Volume 123:Issue 3(2017:Jun.) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Two StereoTactic ablative radiotherapy treatments for localized prostate cancer (2STAR): Results from a prospective clinical trial. (June 2019) Authors: Alayed, Yasir; Cheung, Patrick; Chu, William; Chung, Hans; Davidson, Melanie; Ravi, Ananth; Helou, Joelle; Zhang, Liying; Mamedov, Alexandre; Commisso, Angela; Commisso, Kristina; Loblaw, Andrew Journal: Radiotherapy and oncology Issue: Volume 135(2019) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy. (March 2020) Authors: Alayed, Yasir; Davidson, Melanie; Quon, Harvey; Cheung, Patrick; Chu, William; Chung, Hans T.; Vesprini, Danny; Ong, Aldrich; Chowdhury, Amit; Liu, Stanley K.; Panjwani, Dilip; Helou, Joelle; Musunuru, Hima B.; Pang, Geordi; Korol, Renee; Ravi, Ananth; McCurdy, Boyd; Zhang, Liying; Mamedov, Alexa... Journal: Radiotherapy and oncology Issue: Volume 144(2020) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome. (4th June 2019) Authors: Jeon, Jouhyun; Olkhov-Mitsel, Ekaterina; Xie, Honglei; Yao, Cindy Q; Zhao, Fang; Jahangiri, Sahar; Cuizon, Carmelle; Scarcello, Seville; Jeyapala, Renu; Watson, John D; Fraser, Michael; Ray, Jessica; Commisso, Kristina; Loblaw, Andrew; Fleshner, Neil E; Bristow, Robert G; Downes, Michelle; Vespri... Journal: Journal of the National Cancer Institute Issue: Volume 112:Number 3(2020) Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials. Issue 2 (May 2018) Authors: Alayed, Yasir; Cheung, Patrick; Pang, Geordi; Mamedov, Alexandre; D'Alimonte, Laura; Deabreu, Andrea; Commisso, Kristina; Commisso, Angela; Zhang, Liang; Quon, Harvey C.; Musunuru, Hima Bindu; Helou, Joelle; Loblaw, D. Andrew Journal: Radiotherapy and oncology Issue: Volume 127:Issue 2(2018) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗